Prognostic implications of left ventricular global longitudinal strain in patients with bicuspid aortic valve disease and preserved left ventricular ejection fraction.


Journal

European heart journal. Cardiovascular Imaging
ISSN: 2047-2412
Titre abrégé: Eur Heart J Cardiovasc Imaging
Pays: England
ID NLM: 101573788

Informations de publication

Date de publication:
01 07 2020
Historique:
received: 14 09 2019
accepted: 08 10 2019
pubmed: 22 10 2019
medline: 29 6 2021
entrez: 22 10 2019
Statut: ppublish

Résumé

In patients with bicuspid aortic valve (BAV) and preserved left ventricular (LV) ejection fraction (EF), the frequency of impaired LV global longitudinal strain (GLS) and its prognostic implications are unknown. The present study evaluated the proportion and prognostic value of impaired LV GLS in patients with BAV and preserved LVEF. Five hundred and thirteen patients (68% men; mean age 44 ± 18 years) with BAV and preserved LVEF (>50%) were divided into five groups according to the type of BAV dysfunction: (i) normal function BAV, (ii) mild aortic stenosis (AS) or aortic regurgitation (AR), (iii) ≥moderate isolated AS, (iv) ≥moderate isolated AR, and (v) ≥moderate mixed AS and AR. LV systolic dysfunction based on 2D speckle-tracking echocardiography was defined as a cut-off value of LVGLS (-13.6%). The primary outcome was aortic valve intervention or all-cause mortality. The proportion of patients with LVGLS ≤-13.6% was the highest in the normal BAV group (97%) and the lowest in the group with moderate and severe mixed AS and AR (79%). During a median follow-up of 10 years, 210 (41%) patients underwent aortic valve replacement and 17 (3%) died. Patients with preserved LV systolic function (LVGLS ≤ -13.6%) had significantly better event-free survival compared to those with impaired LV systolic function (LVGLS > -13.6%). LVGLS was independently associated with increased risk of events (mainly aortic valve replacement): hazard ratio 1.09; P < 0.001. Impaired LVGLS in BAV with preserved LVEF is not infrequent and was independently associated with increased risk of events (mainly aortic valve replacement events).

Identifiants

pubmed: 31633159
pii: 5601524
doi: 10.1093/ehjci/jez252
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

759-767

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.

Auteurs

William K F Kong (WKF)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.
Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.

E Mara Vollema (EM)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Francesca Prevedello (F)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Rebecca Perry (R)

Department of Cardiovascular Medicine, Flinders Medical Centre, Bedford Park, Adelaide, Australia.

Arnold C T Ng (ACT)

Department of Cardiology, Princess Alexandra Hospital, The University of Queensland, Australia.

Kian Keong Poh (KK)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.

Ana G Almeida (AG)

Cardiology Department, Santa Maria University Hospital (CHLN), CAML, CCUL, Lisbon School of Medicine of the Universidade de Lisboa, Portugal.

Ariana González (A)

Department of Cardiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Mylène Shen (M)

Quebec Heart and Lung Institute, Laval University, Quebec, Canada.

Tiong Cheng Yeo (TC)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.

Miriam Shanks (M)

Division of Cardiology, University of Alberta, Mazankowski Alberta Heart Institute, Canada.

Bogdan A Popescu (BA)

University of Medicine and Pharmacy "Carol Davila"-Euroecolab, Institute of Cardiovascular Diseases "Prof. Dr. C. C. Iliescu", Bucharest, Romania.

Laura Galian Gay (L)

Department of Cardiology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Marcin Fijałkowski (M)

First Department of Cardiology, Medical University of Gdansk, Poland.

Michael Liang (M)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.
Department of Cardiology, Khoo Teck Puat Hospital, Singapore, Singapore.

Ruth W Chen (RW)

Department of Cardiology, National University Heart Centre, National University Health System, Singapore, Singapore.

Nina Ajmone Marsan (N)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Joseph Selvanayagam (J)

Department of Cardiovascular Medicine, Flinders Medical Centre, Bedford Park, Adelaide, Australia.

Fausto Pinto (F)

Cardiology Department, Santa Maria University Hospital (CHLN), CAML, CCUL, Lisbon School of Medicine of the Universidade de Lisboa, Portugal.

Jose L Zamorano (JL)

Department of Cardiology, Hospital Universitario Ramón y Cajal, Madrid, Spain.

Philippe Pibarot (P)

Quebec Heart and Lung Institute, Laval University, Quebec, Canada.

Arturo Evangelista (A)

Department of Cardiology, Hospital Universitari Vall d'Hebrón, Barcelona, Spain.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Jeroen J Bax (JJ)

Department of Cardiology, Leiden University Medical Center, Albinusdreef 2, 2300 RC Leiden, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH